|
|
|
|
|
|
|
SIZE:
|
|
|
|
GENERIC NAME:
|
|
|
|
MANUFACTURER:
|
|
|
|
UNIT:
|
|
|
|
ADMINISTRATION ROUTE:
|
|
|
|
FDA PREGNANCY GROUP:
|
|
C
|
|
INDICATIONS:
|
|
Glaucoma, open- angle |
|
Hypertension, ocular |
| |
|
|
SIDE EFFECTS:
|
|
Blurred vision |
|
increased length, thickness, pigmentation, and number of eyelashes |
|
increased pigmentation of iris |
|
increased pigmentation of periorbital tissue |
|
punctate epithelial keratopathy |
|
Allergic skin reaction |
|
angina pectoris or other chest pain |
|
eye pain |
|
eyelid crusting, redness, swelling, discomfort, or pain |
|
pain in muscles, joints, or back |
|
upper respiratory tract infection, cold, or flu |
|
Asthma |
|
exacerbation of asthma |
|
conjunctivitis |
|
corneal edema and erosions |
|
diplopia |
|
discharge from the eye |
|
dyspnea |
|
intraocular inflammation, such as iritis or uveitis |
|
macular edema, including cystoid macular edema |
|
toxic epidermal necrolysis |
|
Burning of eye |
|
conjunctival hyperemia |
|
foreign body sensation |
|
itching of eye |
|
stinging of eye |
|
Dryness of eye |
|
photophobia |
|
tearing |
|
|
ABSOLUTE
CONTRAINDICATIONS :
|
|
|
|
RELATIVE
CONTRAINDICATIONS : |
|
>> Aphakia |
|
>> Macular edema, including cystoid macular edema, risk factors for |
|
>> Pseudophakia |
|
Hepatic function impairment |
|
Renal function impairment |
|
Iritis |
|
Uveitis |
|
|
ADULT DOSE:
|
|
Antiglaucoma agent (ophthalmic)
Antihypertensive, ocular-
Topical, to the conjunctiva, 1 drop in the affected eye(s) once a day in the evening . |
|
MAXIMUM ADULT DOSE:
|
|
No more than one dose per day .
|
|
PEDIATRIC DOSE:
|
|
Safety and efficacy have not been established .
|
|
MAXIMUM PEDIATRIC
DOSE:
|
|
|
|
ELDERLY DOSE:
|
|
|
|
|
|
|
|